This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 6 CIPO patents and 4 EPO patents. Top assignee: Pfizer Corporation. Active years: 2002-2015.
Location History:
- Kent, GB (2002)
- County of Kent, GB (2003)
- Sandwich, GB (2004 - 2015)
Company Filing History:
Years Active: 2002-2015
Title: Mark David Andrews: Innovator in Pharmaceutical Chemistry
Introduction
Mark David Andrews is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work primarily focuses on developing innovative compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents are the Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors. This invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, particularly as Trk antagonists. Another significant patent is the Pyrrolo[2,3-d]pyrimidine tropomyosin-related kinase inhibitors, which also involves compounds of Formula (I) and their pharmaceutically acceptable salts, aimed at medical applications as Trk antagonists.
Career Highlights
Throughout his career, Mark has worked with prominent companies such as Pfizer Corporation and Infineum International Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Mark has collaborated with notable professionals in his field, including Donald Stuart Middleton and David Hepworth. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Mark David Andrews is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the development of therapeutic compounds. His contributions continue to impact the medical field positively.